Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
30
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| TRV GP IV, LLC | 10% Owner | 2 | $0 | $3.06M | 2023-02-08 |
| Deardorf Caren | Chief Commercial Officer | 8 | $0 | $42.0K | 2022-11-30 |
| Stants Kristen | Chief People Officer | 9 | $0 | $38.6K | 2022-11-30 |
| Mahoney Stephen F. | See Remarks | 7 | $0 | $38.6K | 2022-11-30 |
| Beetham Thomas W. | See Remarks | 8 | $0 | $41.1K | 2022-11-30 |
| GARDNER JASON | See Remarks | 26 | $6.0K | $1.79M | 2022-11-30 |
| VASCONCELLES MICHAEL | Director | 1 | $0 | $0 | 2022-08-15 |
| Nichols David Wayne | Chief Technical Officer | 7 | $0 | $38.3K | 2022-08-01 |
| Olson Lisa | See Remarks | 9 | $0 | $38.6K | 2022-08-01 |
| Humphrey Jeffrey | Chief Medical Officer | 4 | $0 | $0 | 2022-08-01 |
| McGeorge Anne | Director | 4 | $0 | $0 | 2022-06-28 |
| Scadden David | Director | 9 | $99.0K | $0 | 2022-06-28 |
| Albers Jeffrey W. | Director | 6 | $0 | $0 | 2022-06-28 |
| Lawton Alison Frances | Director | 3 | $0 | $0 | 2022-06-28 |
| Daniel Thomas O | Director | 7 | $0 | $0 | 2022-06-28 |
| Booth Bruce | Director | 11 | $10.00M | $254.4K | 2022-06-28 |
| RONNEBERG AMY L | Director | 8 | $0 | $0 | 2022-06-28 |
| Borisy Alexis | Director | 7 | $0 | $0 | 2021-08-26 |
| Third Rock Ventures GP IV, L.P. | 10% Owner | 4 | $0 | $0 | 2021-08-25 |
| BONNEY MICHAEL W | Director | 6 | $0 | $0 | 2021-06-01 |
| DAVIS JOHN C. JR | See Remarks | 20 | $0 | $508.7K | 2021-02-11 |
| ZDRAVESKI ZORAN | See Remarks | 15 | $0 | $386.9K | 2021-02-11 |
| Atlas Venture Fund X, L.P. | 10% Owner | 1 | $0 | $0 | 2021-02-11 |
| BYERS BLAKE | Director | 5 | $0 | $0 | 2020-06-05 |
| ISACSON CHRISTINA K. | Chief Business Officer | 8 | $0 | $316.6K | 2020-02-10 |
| Ryan Jason | See Remarks | 2 | $0 | $0 | 2020-02-10 |
| COOKE MICHAEL P. | Chief Scientific Officer | 18 | $0 | $654.3K | 2019-12-02 |
| Atlas Venture Associates X, LLC | 10% Owner | 3 | $0 | $254.4K | 2019-03-20 |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 3 | $0 | $0 | 2018-06-25 |
| Alphabet Inc. | 10% Owner | 3 | $0 | $0 | 2018-06-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC | 10% Owner | S Sale | 2023-02-08 | 2023-02-09 | 1,500,000 | $0.82 | $1.23M | 3,058,204 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2023-02-07 | 2023-02-09 | 2,200,000 | $0.83 | $1.83M | 4,558,204 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 20,264 | SEC↗ |
| GARDNER JASON | See Remarks | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 292,872 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 19,762 | SEC↗ |
| Mahoney Stephen F. | See Remarks | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 17,264 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 19,897 | SEC↗ |
| VASCONCELLES MICHAEL | Director | A Award deriv | 2022-08-15 | 2022-08-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award deriv | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award deriv | 2022-08-01 | 2022-08-01 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Mahoney Stephen F. | See Remarks | A Award deriv | 2022-08-01 | 2022-08-01 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | A Award deriv | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2022-08-01 | 2022-08-01 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Humphrey Jeffrey | Chief Medical Officer | A Award deriv | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award deriv | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2022-08-01 | 2022-08-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Scadden David | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Albers Jeffrey W. | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RONNEBERG AMY L | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Daniel Thomas O | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Booth Bruce | Director | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award | 2022-05-31 | 2022-06-06 | 3,000 | $0.99 | $3.0K | 16,897 | SEC↗ |
| GARDNER JASON | See Remarks | A Award | 2022-05-31 | 2022-06-06 | 3,000 | $0.99 | $3.0K | 289,872 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award | 2022-05-31 | 2022-06-06 | 3,000 | $0.99 | $3.0K | 16,762 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award | 2022-05-31 | 2022-06-06 | 3,000 | $0.99 | $3.0K | 17,264 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mahoney Stephen F. | See Remarks | A Award deriv | 2022-05-17 | 2022-05-19 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2022-05-17 | 2022-05-19 | 162,500 | — | $0 | 162,500 | SEC↗ |
| Humphrey Jeffrey | Chief Medical Officer | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Mahoney Stephen F. | See Remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Humphrey Jeffrey | Chief Medical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Humphrey Jeffrey | Chief Medical Officer | A Award deriv | 2021-10-01 | 2021-10-04 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Olson Lisa | See Remarks | S Sale | 2021-09-16 | 2021-09-20 | 5,736 | $6.73 | $38.6K | 14,264 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | S Sale | 2021-09-16 | 2021-09-20 | 5,694 | $6.73 | $38.3K | 14,306 | SEC↗ |
| Beetham Thomas W. | See Remarks | S Sale | 2021-09-16 | 2021-09-20 | 6,103 | $6.73 | $41.1K | 13,897 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2021-09-16 | 2021-09-20 | 14,340 | $6.73 | $96.5K | 286,872 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | S Sale | 2021-09-16 | 2021-09-20 | 6,238 | $6.73 | $42.0K | 13,762 | SEC↗ |
| Mahoney Stephen F. | See Remarks | S Sale | 2021-09-16 | 2021-09-20 | 5,736 | $6.73 | $38.6K | 14,264 | SEC↗ |
| Stants Kristen | Chief People Officer | S Sale | 2021-09-16 | 2021-09-20 | 5,736 | $6.73 | $38.6K | 14,264 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GARDNER JASON | See Remarks | A Award | 2021-09-14 | 2021-09-16 | 50,000 | — | $0 | 301,212 | SEC↗ |
| Mahoney Stephen F. | See Remarks | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Olson Lisa | See Remarks | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Borisy Alexis | Director | J Other | 2021-08-26 | 2021-09-23 | 4,100 | — | $0 | 4,100 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | J Other | 2021-08-25 | 2021-08-26 | 1,250,000 | — | $0 | 6,758,204 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2021-08-02 | 2021-08-03 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award deriv | 2021-08-02 | 2021-08-03 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2021-08-02 | 2021-08-03 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2021-07-20 | 2021-07-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Deardorf Caren | Chief Commercial Officer | A Award deriv | 2021-07-06 | 2021-07-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Beetham Thomas W. | See Remarks | A Award deriv | 2021-06-14 | 2021-06-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Albers Jeffrey W. | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Daniel Thomas O | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Scadden David | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BONNEY MICHAEL W | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| RONNEBERG AMY L | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Booth Bruce | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Lawton Alison Frances | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | A Award deriv | 2021-04-19 | 2021-04-20 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Nichols David Wayne | Chief Technical Officer | A Award deriv | 2021-04-19 | 2021-05-17 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Stants Kristen | Chief People Officer | A Award deriv | 2021-02-11 | 2021-02-16 | 67,500 | — | $0 | 67,500 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2021-02-11 | 2021-02-16 | 112,500 | — | $0 | 112,500 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | A Award deriv | 2021-02-11 | 2021-02-16 | 67,700 | — | $0 | 67,700 | SEC↗ |
| DAVIS JOHN C. JR | See Remarks | A Award deriv | 2021-02-11 | 2021-02-16 | 72,500 | — | $0 | 72,500 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2021-02-11 | 2021-02-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Atlas Venture Fund X, L.P. | 10% Owner | J Other | 2021-02-11 | 2021-02-16 | 968,726 | — | $0 | 3,148,399 | SEC↗ |
| Director | A Award deriv | 2020-12-22 | 2020-12-23 | 36,377 | — | $0 | 36,377 | SEC↗ | |
| Mahoney Stephen F. | See Remarks | A Award deriv | 2020-11-02 | 2020-11-04 | 435,000 | — | $0 | 435,000 | SEC↗ |
| Olson Lisa | See Remarks | A Award deriv | 2020-09-14 | 2020-09-16 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Booth Bruce | Director | P Buy | 2020-06-29 | 2020-07-01 | 1,250,000 | $8.00 | $10.00M | 1,250,000 | SEC↗ |
| Albers Jeffrey W. | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Scadden David | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Daniel Thomas O | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Booth Bruce | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BONNEY MICHAEL W | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| RONNEBERG AMY L | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BYERS BLAKE | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| DAVIS JOHN C. JR | See Remarks | A Award deriv | 2020-04-14 | 2020-04-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2020-02-10 | 2020-02-12 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | A Award deriv | 2020-02-10 | 2020-02-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | A Award deriv | 2020-02-10 | 2020-02-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Ryan Jason | See Remarks | A Award deriv | 2020-02-10 | 2020-02-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | A Award deriv | 2020-02-10 | 2020-02-12 | 104,000 | — | $0 | 104,000 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2020-01-10 | 2020-01-10 | 11,200 | $15.25 | $170.8K | 251,212 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise deriv | 2020-01-02 | 2020-01-03 | 11,294 | — | $0 | 224,831 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2020-01-02 | 2020-01-03 | 2,800 | $15.10 | $42.3K | 262,412 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | S Sale | 2020-01-02 | 2020-01-03 | 11,294 | $15.04 | $169.9K | 8,304 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise | 2020-01-02 | 2020-01-03 | 11,294 | $9.49 | $107.2K | 19,598 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2019-12-24 | 2019-12-30 | 820 | — | $0 | 16,856 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | S Sale | 2019-12-24 | 2019-12-26 | 7,902 | $16.00 | $126.4K | 128,009 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | S Sale | 2019-12-24 | 2019-12-26 | 4,463 | $16.01 | $71.5K | 83,786 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2019-12-24 | 2019-12-30 | 820 | $7.71 | $6.3K | 140,912 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | S Sale | 2019-12-24 | 2019-12-30 | 7,902 | $16.00 | $126.4K | 133,010 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2019-12-23 | 2019-12-30 | 9 | — | $0 | 17,676 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2019-12-23 | 2019-12-30 | 4,172 | — | $0 | 129,342 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2019-12-23 | 2019-12-23 | 2,897 | $15.10 | $43.7K | 265,212 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | S Sale | 2019-12-23 | 2019-12-26 | 9,867 | $16.03 | $158.2K | 88,249 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | S Sale | 2019-12-23 | 2019-12-26 | 4,181 | $16.03 | $67.0K | 135,911 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | S Sale | 2019-12-23 | 2019-12-30 | 4,181 | $16.03 | $67.0K | 140,092 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2019-12-23 | 2019-12-30 | 4,172 | $9.49 | $39.6K | 144,273 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2019-12-23 | 2019-12-30 | 9 | $7.71 | $69 | 140,101 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise deriv | 2019-12-20 | 2019-12-20 | 805 | — | $0 | 236,239 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise deriv | 2019-12-20 | 2019-12-20 | 114 | — | $0 | 236,125 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | S Sale | 2019-12-20 | 2019-12-20 | 919 | $15.00 | $13.8K | 8,304 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise | 2019-12-20 | 2019-12-20 | 805 | $9.49 | $7.6K | 9,223 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise | 2019-12-20 | 2019-12-20 | 114 | $9.49 | $1.1K | 8,418 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2019-12-20 | 2019-12-20 | 76,711 | $15.16 | $1.16M | 268,109 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise deriv | 2019-12-10 | 2019-12-11 | 17,055 | — | $0 | 237,044 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise | 2019-12-10 | 2019-12-11 | 17,055 | $9.49 | $161.9K | 25,359 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | S Sale | 2019-12-10 | 2019-12-11 | 17,055 | $15.00 | $255.8K | 8,304 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2019-12-10 | 2019-12-13 | 4,392 | $15.10 | $66.3K | 344,820 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise deriv | 2019-12-09 | 2019-12-11 | 4,614 | — | $0 | 254,099 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | S Sale | 2019-12-09 | 2019-12-11 | 4,614 | $15.00 | $69.2K | 8,304 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | M Exercise | 2019-12-09 | 2019-12-11 | 4,614 | $9.49 | $43.8K | 12,918 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-12-02 | 2019-12-02 | 3,627 | $12.74 | $46.2K | 244,396 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-12-02 | 2019-12-02 | 2,500 | $13.21 | $33.0K | 240,523 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-12-02 | 2019-12-02 | 1,373 | $13.31 | $18.3K | 243,023 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-11-20 | 2019-11-25 | 5,000 | $12.00 | $60.0K | 248,023 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-11-01 | 2019-11-01 | 5,000 | $10.67 | $53.4K | 253,023 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-10-01 | 2019-10-03 | 5,000 | $10.01 | $50.0K | 258,023 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-09-19 | 2019-09-19 | 1,656 | $12.00 | $19.9K | 263,023 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-09-12 | 2019-09-16 | 844 | $12.00 | $10.1K | 264,679 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-09-03 | 2019-09-04 | 5,000 | $10.11 | $50.5K | 265,523 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-08-01 | 2019-08-01 | 2,500 | $13.41 | $33.5K | 270,523 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-08-01 | 2019-08-01 | 5,000 | $13.42 | $67.1K | 273,023 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-07-01 | 2019-07-02 | 5,000 | $14.39 | $72.0K | 280,523 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-07-01 | 2019-07-02 | 2,500 | $14.42 | $36.0K | 278,023 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2019-06-21 | 2019-06-24 | 12,331 | $15.11 | $186.3K | 349,212 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | S Sale | 2019-06-21 | 2019-06-24 | 5,415 | $16.07 | $87.0K | 98,116 | SEC↗ |
| McGeorge Anne | Director | A Award deriv | 2019-06-20 | 2019-06-24 | 36,377 | — | $0 | 36,377 | SEC↗ |
| GARDNER JASON | See Remarks | S Sale | 2019-06-20 | 2019-06-24 | 1,669 | $15.10 | $25.2K | 361,543 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | S Sale | 2019-06-17 | 2019-06-18 | 7,500 | $13.90 | $104.3K | 285,523 | SEC↗ |
| BONNEY MICHAEL W | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BYERS BLAKE | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Daniel Thomas O | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Booth Bruce | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Scadden David | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| RONNEBERG AMY L | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Albers Jeffrey W. | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| Booth Bruce | Director | J Other | 2019-03-20 | 2019-03-22 | 726,500 | — | $0 | 4,117,125 | SEC↗ |
| Booth Bruce | Director | J Other | 2019-03-20 | 2019-03-22 | 14,245 | — | $0 | 14,245 | SEC↗ |
| Booth Bruce | Director | S Sale | 2019-03-20 | 2019-03-22 | 14,245 | $17.86 | $254.4K | 0 | SEC↗ |
| Atlas Venture Associates X, LL | 10% Owner | J Other | 2019-03-20 | 2019-03-22 | 726,500 | — | $0 | 4,117,125 | SEC↗ |
| Atlas Venture Associates X, LL | 10% Owner | S Sale | 2019-03-20 | 2019-03-22 | 14,245 | $17.86 | $254.4K | 0 | SEC↗ |
| Atlas Venture Associates X, LL | 10% Owner | J Other | 2019-03-20 | 2019-03-22 | 14,245 | — | $0 | 14,245 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | A Award deriv | 2019-02-05 | 2019-02-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| GARDNER JASON | See Remarks | A Award deriv | 2019-02-05 | 2019-02-07 | 182,900 | — | $0 | 182,900 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | A Award deriv | 2019-02-05 | 2019-02-07 | 64,000 | — | $0 | 64,000 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | A Award deriv | 2019-02-05 | 2019-02-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | A Award deriv | 2019-02-05 | 2019-02-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Ryan Jason | See Remarks | A Award deriv | 2019-01-02 | 2019-01-04 | 329,379 | — | $0 | 329,379 | SEC↗ |
| RONNEBERG AMY L | Director | A Award deriv | 2018-09-25 | 2018-09-27 | 52,244 | — | $0 | 52,244 | SEC↗ |
| Borisy Alexis | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 0 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion deriv | 2018-06-25 | 2018-06-27 | 21,459 | — | $0 | 0 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion deriv | 2018-06-25 | 2018-06-27 | 19,314 | — | $0 | 0 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion deriv | 2018-06-25 | 2018-06-27 | 15,000 | — | $0 | 0 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion deriv | 2018-06-25 | 2018-06-27 | 36,700 | — | $0 | 0 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion deriv | 2018-06-25 | 2018-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | C Conversion deriv | 2018-06-25 | 2018-06-27 | 21,459 | — | $0 | 0 | SEC↗ |
| BYERS BLAKE | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 133,400 | — | $0 | 0 | SEC↗ |
| BYERS BLAKE | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 8,494,864 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 10,729 | — | $0 | 0 | SEC↗ |
| BONNEY MICHAEL W | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 6,429 | — | $0 | 0 | SEC↗ |
| BONNEY MICHAEL W | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 50,025 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 12,061,496 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 204,339 | — | $0 | 0 | SEC↗ |
| Alphabet Inc. | 10% Owner | C Conversion deriv | 2018-06-25 | 2018-06-27 | 8,494,864 | — | $0 | 0 | SEC↗ |
| Alphabet Inc. | 10% Owner | C Conversion deriv | 2018-06-25 | 2018-06-27 | 133,400 | — | $0 | 0 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | C Conversion deriv | 2018-06-25 | 2018-06-27 | 857 | — | $0 | 0 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | C Conversion deriv | 2018-06-25 | 2018-06-27 | 6,670 | — | $0 | 0 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | C Conversion deriv | 2018-06-25 | 2018-06-27 | 12,000 | — | $0 | 0 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,287 | — | $0 | 0 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | C Conversion deriv | 2018-06-25 | 2018-06-27 | 10,005 | — | $0 | 0 | SEC↗ |
| RONNEBERG AMY L | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,287,100 | — | $0 | 0 | SEC↗ |
| RONNEBERG AMY L | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 246,781 | — | $0 | 0 | SEC↗ |
| Daniel Thomas O | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 30,028 | — | $0 | 0 | SEC↗ |
| Daniel Thomas O | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 33,350 | — | $0 | 0 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | C Conversion deriv | 2018-06-25 | 2018-06-27 | 340,566 | — | $0 | 0 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | C Conversion deriv | 2018-06-25 | 2018-06-27 | 20,102,478 | — | $0 | 0 | SEC↗ |
| Scadden David | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 16,094 | — | $0 | 0 | SEC↗ |
| Scadden David | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 50,025 | — | $0 | 0 | SEC↗ |
| Scadden David | Director | C Conversion deriv | 2018-06-25 | 2018-06-27 | 6,429 | — | $0 | 0 | SEC↗ |
| ATLAS VENTURE ASSOCIATES X, L. | 10% Owner | C Conversion deriv | 2018-06-25 | 2018-06-27 | 204,339 | — | $0 | 0 | SEC↗ |
| ATLAS VENTURE ASSOCIATES X, L. | 10% Owner | C Conversion deriv | 2018-06-25 | 2018-06-27 | 12,061,496 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | C Conversion | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 0 | SEC↗ |
| GARDNER JASON | See Remarks | P Buy | 2018-06-25 | 2018-06-27 | 400 | $15.00 | $6.0K | 363,212 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion | 2018-06-25 | 2018-06-27 | 25,719 | — | $0 | 292,990 | SEC↗ |
| GARDNER JASON | See Remarks | C Conversion | 2018-06-25 | 2018-06-27 | 21,677 | — | $0 | 359,092 | SEC↗ |
| DAVIS JOHN C. JR | Chief Medical Officer | C Conversion | 2018-06-25 | 2018-06-27 | 8,304 | — | $0 | 8,304 | SEC↗ |
| BYERS BLAKE | Director | C Conversion | 2018-06-25 | 2018-06-27 | 3,339,137 | — | $0 | 3,339,137 | SEC↗ |
| Albers Jeffrey W. | Director | C Conversion | 2018-06-25 | 2018-06-27 | 4,152 | — | $0 | 4,152 | SEC↗ |
| BONNEY MICHAEL W | Director | C Conversion | 2018-06-25 | 2018-06-27 | 21,847 | — | $0 | 215,346 | SEC↗ |
| Booth Bruce | Director | C Conversion | 2018-06-25 | 2018-06-27 | 4,746,876 | — | $0 | 4,843,625 | SEC↗ |
| Alphabet Inc. | 10% Owner | C Conversion | 2018-06-25 | 2018-06-27 | 3,339,137 | — | $0 | 3,339,137 | SEC↗ |
| ISACSON CHRISTINA K. | Chief Business Officer | C Conversion | 2018-06-25 | 2018-06-27 | 2,912 | — | $0 | 103,531 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | C Conversion | 2018-06-25 | 2018-06-27 | 4,643 | — | $0 | 140,092 | SEC↗ |
| COOKE MICHAEL P. | Chief Scientific Officer | C Conversion | 2018-06-25 | 2018-06-27 | 4,370 | — | $0 | 293,023 | SEC↗ |
| RONNEBERG AMY L | Director | C Conversion | 2018-06-25 | 2018-06-27 | 593,611 | — | $0 | 593,611 | SEC↗ |
| Daniel Thomas O | Director | C Conversion | 2018-06-25 | 2018-06-27 | 24,527 | — | $0 | 101,926 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | C Conversion | 2018-06-25 | 2018-06-27 | 7,911,455 | — | $0 | 8,008,204 | SEC↗ |
| Scadden David | Director | P Buy | 2018-06-25 | 2018-06-27 | 6,600 | $15.00 | $99.0K | 228,175 | SEC↗ |
| Scadden David | Director | C Conversion | 2018-06-25 | 2018-06-27 | 28,076 | — | $0 | 221,575 | SEC↗ |
| ATLAS VENTURE ASSOCIATES X, L. | 10% Owner | C Conversion | 2018-06-25 | 2018-06-27 | 4,746,876 | — | $0 | 4,843,625 | SEC↗ |